Syneos health sale.

May 10, 2023 · A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc , a provider of clinical research to drug... May 10, 2023 · A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion ... Sep 28, 2023 · Under the terms of the transaction, Syneos Health stockholders will receive $43.00 in cash for each share of Syneos Health common stock they hold (without interest and subject to any applicable ... Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical …

If to Syneos Health Commercial Services, LLC: Syneos Health Commercial Services, LLC . c/o Syneos Health, Inc. 1030 Sync Street. Morrisville, NC 27560. Attention: General Counsel . with a copy to: Latham & Watkins LLP. 885 3 rd Avenue. New York, NY 10022-4834. Attention: Graeme Smyth, Esq. If to Addison Whitney LLC: Addison Whitney LLC. c/o ...“Syneos Health eyes sale of company as contract backlog shrinks-sources https://t.co/e5BGXrY0x0 @davidcarnevali @asenjourno $SYNH”

Syneos. by WRAL TechWire — May 10, 2023. MORRISVILLE – Syneos Health, a biopharma services company based in Morrisville, is being acquired by a group of investors in a deal worth $7.1 billion ...

Feb 27 (Reuters) - Syneos Health Inc SYNH.O is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its ...Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …Information regarding Syneos Health’s directors and executive officers is contained in Syneos Health’s Annual Report on Form 10-K/A for the year ended December 31, 2022, filed with the SEC on ...Aug 3, 2023 · Syneos Health stockholders approved the firm’s $7.1 billion sale to a consortium of private equity firms, the company said after a special meeting Wednesday. The group taking Syneos private consists of Elliott Investment Management, Patient Square Capital and Veritas Capital. The agreement’s terms call for Syneos stockholders to receive $43 ...

Elliott Investment Management, Patient Square Capital and Veritas Capital are offering to take-private contract-research organization Syneos Health for $43 a share in cash in a transaction valued ...

Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …

Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to trade up 1.7% at $65.60, giving it a market ...Apr 10, 2023 · Syneos Health ( NASDAQ: SYNH) jumped 14% on a report that a handful of private equity firms are said to be interested in the contract research organization. The sales process, which is in its ... Syneos Health has helped to develop or commercialize 92% of novel new drugs approved by the FDA in a recent five-year period. Here, we translate unique clinical, medical affairs and commercial insights to address modern market realities. ... AD/Director, BD Sponsor Sales (Required to be located or work in PST) Location: United States-North ...The average Syneos Health Commercial Solutions salary ranges from approximately $80,339 per year for an Inside Sales Representative to $216,906 per year for an Account Director. The average Syneos Health Commercial Solutions hourly pay ranges from approximately $45 per hour for a Recruiter to $45 per hour for a Recruiter. …Salaries at Syneos Health range from an average of $54,174 to $140,819 a year. Syneos Health employees with the job title Senior Clinical Research Associate (CRA) make the most with an average ...Syneos Health, a global contract research organization (CRO) headquartered in Morrisville, will likely be sold to a consortium of private investment firms in a deal valued at $7.1 billion.. The publicly traded company has signed a definitive agreement to be taken private by Elliott Investment Management, Patient Square Capital and …

Apr 10, 2023 · Syneos Health ( NASDAQ: SYNH) jumped 14% on a report that a handful of private equity firms are said to be interested in the contract research organization. The sales process, which is in its ... Kirkland & Ellis represents health care investment firm Patient Square Capital, as part of a consortium of private investment firm affiliates including Elliott Investment Management and Veritas Capital, which announced today that they have entered into a definitive agreement to acquire Syneos Health, Inc. (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, in a ...Walking and running are both great forms of aerobic exercise — and they both come with great health benefits. Regularly walking or running can strengthen your bones, heart and lungs and help you stay at a healthy weight. But there are some ...Syneos Health received an acquisition offer from a PE consortium of c.$7.1 billion. The transaction involves an all-cash consideration of $43.00 per share, a 1.7% premium over SYNH's stock price ...Raleigh, United States. 10000+ Employees. 16 Locations. Type: Company - Private. Revenue: Unknown / Non-Applicable. Biotech & Pharmaceuticals. Competitors: IQVIA Create Comparison. Syneos Health® (Nasdaq: SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success.From 2008 to 2021, Mr. Bonello held roles of increasing responsibility at Nasdaq-listed PRA Health Sciences, Inc., including Executive Vice President and Chief Financial Officer from 2018 through ...

Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to creating better, smarter, faster ways to get biopharmaceutical therapies to patients. Experience the thrill of knowing that your everyday efforts are ...

Drug trials company Syneos to be acquired for $7.1 billion. Syneos Health, a North Carolina-based biopharma contract research organization, agreed to be taken private for $7.1 billion by an investor group that includes Elliott Investment Management, Patient Square Capital and Veritas Capital. Why it matters: Private equity firms are once again ...NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Syneos Health, Inc. (Syneos Health has launched more sales teams in the last 5 years across all major therapeutic areas than the top 25 pharma companies combined. Join our game-changing, global company dedicated to creating better, smarter, faster ways to get biopharmaceutical therapies to patients. Experience the thrill of knowing that your everyday efforts are ...Mar 21, 2023 · 2:14 pm. Source: Getty Images. Syneos Health cemented a multi-year deal to use Microsoft ’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week centers on an advanced analytics platform, which Syneos built on Microsoft’s Azure technology, that enables agile ... By Reuters News Agency Shares of Syneos Health Inc rose 13% after Reuters exclusively reported that the company is making a new effort to sell itself. The effort comes in the wake of a reduced backlog of contracts for providing clinical research to drug developers that led to a plunge in the value of its shares over the past year.Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc 's acquisition of inVentiv Health Inc for $7.4 billion, including debt.Mar 9, 2020 · Syneos shares were trading down 30% because of the stock market rout before the Reuters story on Monday, but jumped on the news of the possible sale to trade up 1.7% at $65.60, giving it a market ... Iryna Drozd. Reported private equity interest in Syneos Health. On Monday (April 10th), Dealreporter put out an article that at least four parties are in the second round of a sale process ...SYNH. for more than $7 billion, including debt. Bloomberg News first reported the news of the investment consortium's talks with Syneos. The consortium will pay about $43 per share in cash for ...

Sep 28, 2023 · Syneos Health has officially gone private, the company announced Thursday morning. The 2023 MM+M Agency 100 honoree completed the $7.1 billion all-cash transaction with a cohort of private equity firms, including Elliott Investment Management, Patient Square Capital and Veritas Capital. The deal was first announced in May with the unanimous ...

Headquartered in Morrisville, North Carolina, Syneos Health, Inc. (NASDAQ:SYNH) is a biopharmaceutical company. On March 16, 2023, Syneos Health, Inc. (NASDAQ:SYNH) stock closed at $34.34 per ...

Salaries at Syneos Health range from an average of $54,174 to $140,819 a year. Syneos Health employees with the job title Senior Clinical Research Associate (CRA) make the most with an average ...11 de mai. de 2023 ... Syneos Health SYNH recently entered into a definitive agreement to be acquired by a private investment consortium in an all-cash transaction ...NEW YORK (Reuters) -A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc, a provider of clinical research to drug developers, for more than $7 billion, including debt, people familiar with the matter said. The consortium will pay about $43 per share in cash for Syneos, the sources said. Syneos Chief ...May 10, 2023 · A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc , a provider of clinical research to drug... Report: Syneos Health explores sale amid life sciences consolidation. Triangle Business Journal. Feb 17, 2023. ... CEO of Syneos Health. Triangle Business Journal. Oct 25, 2022.30d+. Syneos Health. Sr Medical Writer (Publication) United States. $61K - $155K (Employer est.) 7d. Syneos Health. Sr Analytical Scientist (Bioanalytical, 3-5yr Exp) Princeton, NJ.Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc 's acquisition of inVentiv Health Inc for $7.4 billion, including debt.Analysts are somewhat split on Syneos Health stock in general. Currently, analyst consensus calls it a Hold based on one Buy, three Holds, and two Sells. In addition, its average price target of ...Syneos Health, Inc. is a biopharmaceutical solutions company that utilizes outsourced clinical drug development and commercialization services. The Company operates through two business segments: Clinical Solutions and Commercial Solutions.Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …Feb 27, 2023 · Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year ... Syneos Health ® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Together we share insights, use the latest technologies and apply advanced business practices to speed our …

We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com. 1030 Sync Street Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.Feb 27, 2023 · Syneos saw it stock price drop around 50 percent in the past year. Shares were trading up about 10 percent Monday on news of the sale talks with prices at $41.30 in the early afternoon. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com. 1030 Sync Street Morrisville, NC 27560. Phone: 919 876 9300 Fax: 919 876 9360 Toll-Free: 866 462 7373.Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc 's acquisition of inVentiv Health Inc for $7.4 billion, including debt.Instagram:https://instagram. short duration treasury etfschwab ameritrademsft ex dividend datewhat does short the stock mean Feb 28, 2023 · Following is a summary of current health news briefs. Exclusive-Syneos Health eyes sale of company as contract backlog shrinks-sources. Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the past year, according to people familiar with the matter. stock broker commission percentagehymb etf Syneos Health. Investor Relations: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 [email protected]. Press/Media: Danielle DeForge klaviyo ipo Syneos Health has officially gone private, the company announced Thursday morning. The 2023 MM+M Agency 100 honoree completed the $7.1 billion all-cash transaction with a cohort of private equity firms, including Elliott Investment Management, Patient Square Capital and Veritas Capital. The deal was first announced in May with the unanimous ...2:56. A consortium backed by Elliott Investment Management agreed to buy drug-research services company Syneos Health Inc. for about $4.4 billion. The investor group also includes …